Steve Harvey (L), Camena Bioscience CEO and co-founder, and Derek Stemple, CSO and co-founder (Camena Bioscience)
DNA synthesis upstart raises $10M to scale operations
Camena Bioscience, a UK biotech, raised $10 million as it works on improving the accuracy of DNA synthesis.
The Series A, led by UK venture …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
